Skip to main content

29.03.2024 | Research Article

Critical care pharmacy service provision and workforce in adult extracorporeal membrane oxygenation centres: a multicentre cross-sectional survey

verfasst von: Christopher Remmington, Lynda Cameron, Fraser Hanks, Ya-Hui Liang, Linda Barrow, Ruth Coxhead, Reena Mehta, Nisha Bhudia, Haifa Lyster, Sarah Cooke, James Gilmartin, Phillisa Lee, Rhona Sloss, Cathrine McKenzie

Erschienen in: International Journal of Clinical Pharmacy

Einloggen, um Zugang zu erhalten

Abstract

Background

There is good evidence describing pharmacy workforce and service provision in general critical care units. However, no data exist from adult extracorporeal membrane oxygenation (ECMO) centres.

Aim

To describe workforce characteristics, pharmacy service provision, and pharmaceutical care activities in critical care units (CCUs) providing an adult ECMO service in the United Kingdom (UK) and compare to national staffing standards for CCUs.

Method

We conducted a multicentre, cross-sectional electronic survey inviting one pharmacy professional response per UK ECMO centre. We collated information on workforce, service provision, and pharmaceutical care activities provided by pharmacy teams in adult CCUs with an ECMO service.

Results

The survey response rate was 90.9%: representatives of 10/11 tertiary hospitals providing ECMO services responded. Median critical care pharmacist to critical care bed was 1:12.1 (IQR: 1:9.4–1:14.9). Most centres (90.0%) did not meet national standards for pharmacy professionals to critical care bed staffing ratios for weekday services. Total critical care beds covered by the critical care pharmacy team varied across the UK: median (IQR) – 45 (37–80) beds. Two centres funded pharmacist time for ECMO activity, and one centre funded a pharmacy technician post. Median peak ECMO activity was 4 ECMO patients in a single day (IQR: 3–5). Most respondents reported reduced pharmacy service at weekends compared to weekday, with limited on-site support.

Conclusion

Most responding ECMO centres in the UK reported pharmacy staffing ratios below nationally agreed critical care standards. There was high variability in clinical pharmacy services to ECMO patients over 7 days.
Literatur
1.
Zurück zum Zitat Kopp BJ, Mrsan M, Erstad BL, et al. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64:2483–7.CrossRefPubMed Kopp BJ, Mrsan M, Erstad BL, et al. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64:2483–7.CrossRefPubMed
2.
Zurück zum Zitat MacLaren R, Roberts RJ, Dzierba AL, et al. Characterizing critical care pharmacy services across the united states. Crit Care Explor. 2021;3:e0323.CrossRefPubMedPubMedCentral MacLaren R, Roberts RJ, Dzierba AL, et al. Characterizing critical care pharmacy services across the united states. Crit Care Explor. 2021;3:e0323.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Lee H, Ryu K, Sohn Y, et al. Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams: a systematic review and meta-analysis. Crit Care Med. 2019;47:1243–50.CrossRefPubMed Lee H, Ryu K, Sohn Y, et al. Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams: a systematic review and meta-analysis. Crit Care Med. 2019;47:1243–50.CrossRefPubMed
4.
Zurück zum Zitat Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691–8.CrossRefPubMed Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691–8.CrossRefPubMed
5.
Zurück zum Zitat Rudall N, McKenzie C, Landa J, et al. Protected-UK–Clinical pharmacist interventions in the UK critical care unit: exploration of relationship between intervention, service characteristics and experience level. Int J Pharm Pract. 2017;25:311–9.CrossRefPubMed Rudall N, McKenzie C, Landa J, et al. Protected-UK–Clinical pharmacist interventions in the UK critical care unit: exploration of relationship between intervention, service characteristics and experience level. Int J Pharm Pract. 2017;25:311–9.CrossRefPubMed
7.
Zurück zum Zitat Hanks F, Philips B, Barton G, et al. How critical illness impacts drug pharmacokinetics and pharmacodynamics. Pharm J 2022. Hanks F, Philips B, Barton G, et al. How critical illness impacts drug pharmacokinetics and pharmacodynamics. Pharm J 2022.
9.
Zurück zum Zitat Seston EM, Ashcroft DM, Lamerton E, et al. Evaluating the implementation and impact of a pharmacy technician-supported medicines administration service designed to reduce omitted doses in hospitals: a qualitative study. BMC Health Serv Res. 2019;19:325.CrossRefPubMedPubMedCentral Seston EM, Ashcroft DM, Lamerton E, et al. Evaluating the implementation and impact of a pharmacy technician-supported medicines administration service designed to reduce omitted doses in hospitals: a qualitative study. BMC Health Serv Res. 2019;19:325.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Rathbone AP, Jamie K, Blackburn J, et al. Exploring an extended role for pharmacy assistants on inpatient wards in UK hospitals: using mixed methods to develop the role of medicines assistants. Eur J Hosp Pharm. 2020;27:78–83.CrossRefPubMed Rathbone AP, Jamie K, Blackburn J, et al. Exploring an extended role for pharmacy assistants on inpatient wards in UK hospitals: using mixed methods to develop the role of medicines assistants. Eur J Hosp Pharm. 2020;27:78–83.CrossRefPubMed
13.
Zurück zum Zitat Shekar K, Fraser JF, Smith MT, et al. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care. 2012;27:741.e9-741.e18.CrossRefPubMed Shekar K, Fraser JF, Smith MT, et al. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care. 2012;27:741.e9-741.e18.CrossRefPubMed
14.
Zurück zum Zitat Shekar K, Roberts JA, Mcdonald CI, et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care. 2012;16:R194.CrossRefPubMedPubMedCentral Shekar K, Roberts JA, Mcdonald CI, et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care. 2012;16:R194.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Boucher BA, Wood GC, Swanson JM. Pharmacokinetic Changes in Critical Illness. Crit Care Clin. 2006;22:255–71.CrossRefPubMed Boucher BA, Wood GC, Swanson JM. Pharmacokinetic Changes in Critical Illness. Crit Care Clin. 2006;22:255–71.CrossRefPubMed
16.
Zurück zum Zitat Remmington C, McKenzie C, Camporota L, et al. Analgosedation in extracorporeal membrane oxygenation: a retrospective UK cohort study. Br J Anaesth 2023:S0007091223002477. Remmington C, McKenzie C, Camporota L, et al. Analgosedation in extracorporeal membrane oxygenation: a retrospective UK cohort study. Br J Anaesth 2023:S0007091223002477.
17.
Zurück zum Zitat Barrett NA, Jones A, Whiteley C, et al. Management of long-term hypothyroidism: a potential marker of quality of medicines reconciliation in the intensive care unit†. Int J Pharm Pract. 2012;20:303–6.CrossRefPubMed Barrett NA, Jones A, Whiteley C, et al. Management of long-term hypothyroidism: a potential marker of quality of medicines reconciliation in the intensive care unit†. Int J Pharm Pract. 2012;20:303–6.CrossRefPubMed
19.
Zurück zum Zitat Borthwick M, Barton G, Bourne RS, et al. Critical care pharmacy workforce: UK deployment and characteristics in 2015. Int J Pharm Pract. 2018;26:325–33.CrossRefPubMed Borthwick M, Barton G, Bourne RS, et al. Critical care pharmacy workforce: UK deployment and characteristics in 2015. Int J Pharm Pract. 2018;26:325–33.CrossRefPubMed
20.
Zurück zum Zitat Borthwick M, Barton G, Ioannides CP, et al. Critical care pharmacy workforce: a 2020 re-evaluation of the UK deployment and characteristics. Hum Resour Health. 2023;21:28.CrossRefPubMedPubMedCentral Borthwick M, Barton G, Ioannides CP, et al. Critical care pharmacy workforce: a 2020 re-evaluation of the UK deployment and characteristics. Hum Resour Health. 2023;21:28.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Cheng C, Walsh A, Jones S, et al. Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic. Int J Clin Pharm. 2023;45:293–303.CrossRefPubMed Cheng C, Walsh A, Jones S, et al. Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic. Int J Clin Pharm. 2023;45:293–303.CrossRefPubMed
22.
Zurück zum Zitat Oakley R, Al-Mahdi S, Guntschnig S, et al. Defining international critical care pharmacist contributions to sepsis and exploring variability. Curr Infect Dis Rep. 2024;26:15–29.CrossRef Oakley R, Al-Mahdi S, Guntschnig S, et al. Defining international critical care pharmacist contributions to sepsis and exploring variability. Curr Infect Dis Rep. 2024;26:15–29.CrossRef
25.
Zurück zum Zitat Dee J, Dhuhaibawi N, Hayden JC. A systematic review and pooled prevalence of burnout in pharmacists. Int J Clin Pharm. 2023;45(5):1027–36.CrossRefPubMed Dee J, Dhuhaibawi N, Hayden JC. A systematic review and pooled prevalence of burnout in pharmacists. Int J Clin Pharm. 2023;45(5):1027–36.CrossRefPubMed
26.
Zurück zum Zitat Newsome AS, Smith SE, Jones TW, et al. A survey of critical care pharmacists to patient ratios and practice characteristics in intensive care units. J Am Coll Clin Pharm. 2020;3:68–74.CrossRef Newsome AS, Smith SE, Jones TW, et al. A survey of critical care pharmacists to patient ratios and practice characteristics in intensive care units. J Am Coll Clin Pharm. 2020;3:68–74.CrossRef
27.
Zurück zum Zitat Jebara T, Cunningham S, MacLure K, et al. Stakeholders’ views and experiences of pharmacist prescribing: a systematic review: views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol. 2018;84:1883–905.CrossRefPubMedPubMedCentral Jebara T, Cunningham S, MacLure K, et al. Stakeholders’ views and experiences of pharmacist prescribing: a systematic review: views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol. 2018;84:1883–905.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Weeks G, George J, Maclure K, et al. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev 2016; 2017. Weeks G, George J, Maclure K, et al. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev 2016; 2017.
29.
Zurück zum Zitat Bourne RS, Whiting P, Brown LS, et al. Pharmacist independent prescribing in critical care: results of a national questionnaire to establish the 2014 UK position. Int J Pharm Pract. 2016;24:104–13.CrossRefPubMed Bourne RS, Whiting P, Brown LS, et al. Pharmacist independent prescribing in critical care: results of a national questionnaire to establish the 2014 UK position. Int J Pharm Pract. 2016;24:104–13.CrossRefPubMed
30.
Zurück zum Zitat Handel AE, Patel SV, Skingsley A, et al. Weekend admissions as an independent predictor of mortality: an analysis of Scottish hospital admissions. BMJ Open. 2012;2:e001789.CrossRefPubMedPubMedCentral Handel AE, Patel SV, Skingsley A, et al. Weekend admissions as an independent predictor of mortality: an analysis of Scottish hospital admissions. BMJ Open. 2012;2:e001789.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat MacLaren R, Bond CA, Martin SJ, et al. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36:3184–9.CrossRefPubMed MacLaren R, Bond CA, Martin SJ, et al. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36:3184–9.CrossRefPubMed
Metadaten
Titel
Critical care pharmacy service provision and workforce in adult extracorporeal membrane oxygenation centres: a multicentre cross-sectional survey
verfasst von
Christopher Remmington
Lynda Cameron
Fraser Hanks
Ya-Hui Liang
Linda Barrow
Ruth Coxhead
Reena Mehta
Nisha Bhudia
Haifa Lyster
Sarah Cooke
James Gilmartin
Phillisa Lee
Rhona Sloss
Cathrine McKenzie
Publikationsdatum
29.03.2024
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-024-01719-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.